June 11, 2025 8-Week Oral Therapy Approved for Acute HCV The FDA has approved Mavyret for the treatment of acute hepatitis C, offering physicians a pangenotypic, 8-week oral regimen for early intervention. Conexiant
Pharmacologic Toll-like Receptor 4 Inhibition Ameliorates Early Astrogliosis Improving Neurocognitive Outcomes Following Traumatic Brain Injury
Slowing of Junctional Escape Rhythm Following Atrioventricular Node Ablation in a Porcine Model of Complete AV Block
June 10, 2025 Digital Histopathology and Automated Classification of Pediatric Sarcomas The ASCO Post
April 30, 2025 AACR 2025: AI-Driven Analysis of Digital Pathology Images May Improve Sarcoma Subtyping Among Pediatric Patients The ASCO Post
June 10, 2024 How the Museum of Medicine and Biomedical Discovery Aims to Bring Scientific Achievements of the Past, Present, and Future to Life The ASCO Post